Get started
Author

Deepna Balakrishnan

ORCID: 0000-0001-7612-0218
Observed ORCID: 0000-0001-7612-0218
OpenAlex ID: A5094281997
FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
2025 · Vikas Duhan, Ma. Ricci Gomez, et al. · Cancer Immunology Research · 2
Systems and Computational Screening identifies SRC and NKIRAS2 as Baseline Correlates of Risk (CoR) for Live Attenuated Oral Typhoid Vaccine (TY21a) associated Protection
2024 · Akshayata Naidu, Varin Garg, et al. · Molecular Immunology · 1
Data from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
2025 · Vikas Duhan, Ma. Ricci Gomez, et al.
Supplementary Figure S1 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
2025 · Vikas Duhan, Ma. Ricci Gomez, et al.
Supplementary Figure S3 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
2025 · Vikas Duhan, Ma. Ricci Gomez, et al.
Supplementary Figure S2 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
2025 · Vikas Duhan, Ma. Ricci Gomez, et al.
Supplementary Figure S8 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
2025 · Vikas Duhan, Ma. Ricci Gomez, et al.
Supplementary Figure S6 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
2025 · Vikas Duhan, Ma. Ricci Gomez, et al.
Supplementary Figure S4 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
2025 · Vikas Duhan, Ma. Ricci Gomez, et al.
Supplementary Figure S7 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
2025 · Vikas Duhan, Ma. Ricci Gomez, et al.
Supplementary Figure S10 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
2025 · Vikas Duhan, Ma. Ricci Gomez, et al.
Supplementary Figure S9 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
2025 · Vikas Duhan, Ma. Ricci Gomez, et al.
Supplementary Figure S5 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
2025 · Vikas Duhan, Ma. Ricci Gomez, et al.
Supplementary Table 2 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
2025 · Vikas Duhan, Ma. Ricci Gomez, et al.
Supplementary Table 1 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
2025 · Vikas Duhan, Ma. Ricci Gomez, et al.
Supplementary Table 3 from FcRγ-Dependent NK Cell Licensing through CD244 Promotes Antitumor Immunity
2025 · Vikas Duhan, Ma. Ricci Gomez, et al.
Works count: 16
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type